These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 1544857
1. Sensitization of drug resistant human ovarian cancer cells to cyanomorpholino doxorubicin (MRA-CN) by modulation of glutathione metabolism. Lewis AD, Durán GE, Lau DH, Sikic BI. Int J Radiat Oncol Biol Phys; 1992; 22(4):821-4. PubMed ID: 1544857 [Abstract] [Full Text] [Related]
2. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Lau DH, Lewis AD, Ehsan MN, Sikic BI. Cancer Res; 1991 Oct 01; 51(19):5181-7. PubMed ID: 1717140 [Abstract] [Full Text] [Related]
3. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance. Xu BH, Gupta V, Singh SV. Arch Biochem Biophys; 1994 Jan 01; 308(1):164-70. PubMed ID: 8311448 [Abstract] [Full Text] [Related]
4. Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyanomorpholino doxorubicin. Lau DH, Ross KL, Sikic BI. Cancer Res; 1990 Jul 01; 50(13):4056-60. PubMed ID: 2162251 [Abstract] [Full Text] [Related]
5. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. Chen G, Waxman DJ. Biochem Pharmacol; 1994 Mar 15; 47(6):1079-87. PubMed ID: 8147907 [Abstract] [Full Text] [Related]
6. DNA cross-linking and cytotoxicity of the alkylating cyanomorpholino derivative of doxorubicin in multidrug-resistant cells. Scudder SA, Brown JM, Sikic BI. J Natl Cancer Inst; 1988 Oct 19; 80(16):1294-8. PubMed ID: 3172256 [Abstract] [Full Text] [Related]
7. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067. Xu BH, Singh SV. Cancer Res; 1992 Dec 01; 52(23):6666-70. PubMed ID: 1423311 [Abstract] [Full Text] [Related]
8. Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells. Chen G, Waxman DJ. Biochem Pharmacol; 1995 May 26; 49(11):1691-701. PubMed ID: 7786310 [Abstract] [Full Text] [Related]
9. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line. Chao CC, Huang YT, Ma CM, Chou WY, Lin-Chao S. Mol Pharmacol; 1992 Jan 26; 41(1):69-75. PubMed ID: 1346333 [Abstract] [Full Text] [Related]
10. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines. Lai GM, Moscow JA, Alvarez MG, Fojo AT, Bates SE. Int J Cancer; 1991 Nov 11; 49(5):688-95. PubMed ID: 1682279 [Abstract] [Full Text] [Related]
11. Role of glutathione and glutathione S-transferase in chlorambucil resistance. Yang WZ, Begleiter A, Johnston JB, Israels LG, Mowat MR. Mol Pharmacol; 1992 Apr 11; 41(4):625-30. PubMed ID: 1569917 [Abstract] [Full Text] [Related]
12. Activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin in sensitive and resistant L5178Y lymphoblasts in vitro. Begleiter A, Leith MK, Johnston JB. Cancer Res; 1994 Jan 15; 54(2):482-6. PubMed ID: 8275485 [Abstract] [Full Text] [Related]
13. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines. Mistry P, Loh SY, Kelland LR, Harrap KR. Int J Cancer; 1993 Nov 11; 55(5):848-56. PubMed ID: 8244583 [Abstract] [Full Text] [Related]
14. Markedly decreased expression of glutathione S-transferase pi gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis. Yokomizo A, Kohno K, Wada M, Ono M, Morrow CS, Cowan KH, Kuwano M. J Biol Chem; 1995 Aug 18; 270(33):19451-7. PubMed ID: 7642628 [Abstract] [Full Text] [Related]
15. Role of glutathione and its associated enzymes in multidrug-resistant human myeloma cells. Bellamy WT, Dalton WS, Meltzer P, Dorr RT. Biochem Pharmacol; 1989 Mar 01; 38(5):787-93. PubMed ID: 2930579 [Abstract] [Full Text] [Related]
16. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity. Alaoui-Jamali MA, Panasci L, Centurioni GM, Schecter R, Lehnert S, Batist G. Cancer Chemother Pharmacol; 1992 Mar 01; 30(5):341-7. PubMed ID: 1505071 [Abstract] [Full Text] [Related]
17. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells. Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K. Oncol Res; 1995 Mar 01; 7(3-4):191-200. PubMed ID: 8555653 [Abstract] [Full Text] [Related]
18. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Ozols RF, Louie KG, Plowman J, Behrens BC, Fine RL, Dykes D, Hamilton TC. Biochem Pharmacol; 1987 Jan 01; 36(1):147-53. PubMed ID: 3801051 [Abstract] [Full Text] [Related]
19. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells. Lutzky J, Astor MB, Taub RN, Baker MA, Bhalla K, Gervasoni JE, Rosado M, Stewart V, Krishna S, Hindenburg AA. Cancer Res; 1989 Aug 01; 49(15):4120-5. PubMed ID: 2568167 [Abstract] [Full Text] [Related]
20. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice. Ford JM, Yang JM, Hait WN. Cancer Res; 1991 Jan 01; 51(1):67-72. PubMed ID: 1988108 [Abstract] [Full Text] [Related] Page: [Next] [New Search]